200 related articles for article (PubMed ID: 21883135)
1. Urinary placental growth factor differentiates the hypertensive disorders of pregnancy.
Campbell N; Ogle R; Thornton C; Hennessy A; Abbott J
Aust N Z J Obstet Gynaecol; 2011 Dec; 51(6):523-6. PubMed ID: 21883135
[TBL] [Abstract][Full Text] [Related]
2. First trimester urinary placental growth factor and development of pre-eclampsia.
Savvidou MD; Akolekar R; Zaragoza E; Poon LC; Nicolaides KH
BJOG; 2009 Apr; 116(5):643-7. PubMed ID: 19220238
[TBL] [Abstract][Full Text] [Related]
3. Low urinary placental growth factor is a marker of pre-eclampsia.
Aggarwal PK; Jain V; Sakhuja V; Karumanchi SA; Jha V
Kidney Int; 2006 Feb; 69(3):621-4. PubMed ID: 16395263
[TBL] [Abstract][Full Text] [Related]
4. First-trimester placental protein 13 and placental growth factor: markers for identification of women destined to develop early-onset pre-eclampsia.
Wortelboer EJ; Koster MP; Cuckle HS; Stoutenbeek PH; Schielen PC; Visser GH
BJOG; 2010 Oct; 117(11):1384-9. PubMed ID: 20840693
[TBL] [Abstract][Full Text] [Related]
5. Urinary placental growth factor and risk of preeclampsia.
Levine RJ; Thadhani R; Qian C; Lam C; Lim KH; Yu KF; Blink AL; Sachs BP; Epstein FH; Sibai BM; Sukhatme VP; Karumanchi SA
JAMA; 2005 Jan; 293(1):77-85. PubMed ID: 15632339
[TBL] [Abstract][Full Text] [Related]
6. Oxidative stress in midpregnancy as a predictor of gestational hypertension and pre-eclampsia.
Rogers MS; Wang CC; Tam WH; Li CY; Chu KO; Chu CY
BJOG; 2006 Sep; 113(9):1053-9. PubMed ID: 16956336
[TBL] [Abstract][Full Text] [Related]
7. Alterations of serum and placental endoglin in pre-eclampsia.
Fang M; He Y; Li H; Wu M; Shi X; Du H
J Int Med Res; 2010; 38(1):43-51. PubMed ID: 20233512
[TBL] [Abstract][Full Text] [Related]
8. Prediction of pre-eclampsia in early pregnancy by estimating the spot urinary albumin: creatinine ratio using high-performance liquid chromatography.
Baweja S; Kent A; Masterson R; Roberts S; McMahon LP
BJOG; 2011 Aug; 118(9):1126-32. PubMed ID: 21481153
[TBL] [Abstract][Full Text] [Related]
9. [Value of second trimester maternal serum sFlt-1, PlGF and their ratio in the prediction of preeclampsia].
Gao J; Shen J; Jiang Y; Zhou X; Qi H; Liu X; Liu J; Yang J; Bian X
Zhonghua Fu Chan Ke Za Zhi; 2014 Jan; 49(1):22-5. PubMed ID: 24694913
[TBL] [Abstract][Full Text] [Related]
10. [Investigate of three-dimensional power Doppler ultrasound used in placental perfusion assessment in pre-eclampsia pregnancies].
Ma XQ; Wu QQ; Li P; Wang Q; Li M
Zhonghua Fu Chan Ke Za Zhi; 2009 Mar; 44(3):179-82. PubMed ID: 19570441
[TBL] [Abstract][Full Text] [Related]
11. Inhibin A, activin A, placental growth factor and uterine artery Doppler pulsatility index in the prediction of pre-eclampsia.
Yu J; Shixia CZ; Wu Y; Duan T
Ultrasound Obstet Gynecol; 2011 May; 37(5):528-33. PubMed ID: 20737451
[TBL] [Abstract][Full Text] [Related]
12. Placenta growth factor is not an early marker for the development of severe preeclampsia.
Livingston JC; Haddad B; Gorski LA; Neblett P; Ahokas RA; Ramsey R; Sibai BM
Am J Obstet Gynecol; 2001 May; 184(6):1218-20. PubMed ID: 11349191
[TBL] [Abstract][Full Text] [Related]
13. The role of urinary soluble endoglin in the diagnosis of pre-eclampsia: comparison with soluble fms-like tyrosine kinase 1 to placental growth factor ratio.
Buhimschi CS; Baumbusch MA; Dulay AT; Lee S; Wehrum M; Zhao G; Bahtiyar MO; Pettker CM; Ali UA; Funai EF; Buhimschi IA
BJOG; 2010 Feb; 117(3):321-30. PubMed ID: 19943826
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a rapid and simple placental growth factor test in hypertensive disorders of pregnancy.
Gullai N; Stenczer B; Molvarec A; Fügedi G; Veresh Z; Nagy B; Rigó J
Hypertens Res; 2013 May; 36(5):457-62. PubMed ID: 23324863
[TBL] [Abstract][Full Text] [Related]
15. Placental expression of VEGF family mRNA in adverse pregnancy outcomes.
Andraweera PH; Dekker GA; Laurence JA; Roberts CT
Placenta; 2012 Jun; 33(6):467-72. PubMed ID: 22386962
[TBL] [Abstract][Full Text] [Related]
16. Endoglin, PlGF and sFlt-1 as markers for predicting pre-eclampsia.
De Vivo A; Baviera G; Giordano D; Todarello G; Corrado F; D'anna R
Acta Obstet Gynecol Scand; 2008; 87(8):837-42. PubMed ID: 18607829
[TBL] [Abstract][Full Text] [Related]
17. Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension.
Noori M; Donald AE; Angelakopoulou A; Hingorani AD; Williams DJ
Circulation; 2010 Aug; 122(5):478-87. PubMed ID: 20644016
[TBL] [Abstract][Full Text] [Related]
18. Can serum HCG values be used in the differential diagnosis of pregnancy complicated by hypertension?
Gurbuz A; Karateke A; Mengulluoglu M; Gedikbasi A; Ozturkmen M; Kabaca C; Sahinoglu Z
Hypertens Pregnancy; 2004; 23(1):1-12. PubMed ID: 15117595
[TBL] [Abstract][Full Text] [Related]
19. Urinary excretion of C5b-9 is associated with the anti-angiogenic state in severe preeclampsia.
Guseh SH; Feinberg BB; Dawood HY; Yamamoto HS; Fichorova RN; Burwick RM
Am J Reprod Immunol; 2015 May; 73(5):437-44. PubMed ID: 25521546
[TBL] [Abstract][Full Text] [Related]
20. Plasma kisspeptin levels in pregnancies with diabetes and hypertensive disease as a potential marker of placental dysfunction and adverse perinatal outcome.
Cetković A; Miljic D; Ljubić A; Patterson M; Ghatei M; Stamenković J; Nikolic-Djurovic M; Pekic S; Doknic M; Glišić A; Bloom S; Popovic V
Endocr Res; 2012; 37(2):78-88. PubMed ID: 22489921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
